文献速递神经肿瘤

复发高级别胶质瘤迭代手术治疗的作用与实际效果:一项观察性分析队列研究

The Role and Real Effect of an Iterative Surgical Approach for the Management of Recurrent High-Grade Glioma: An Observational Analytic Cohort Study.
PubMed 文献 · World Neurosurg · 2019-01-03

该观察性分析队列研究纳入2004至2014年间接受手术的78例高级别胶质瘤患者,评估重复手术对生存参数的实际效果,并与78例接受辅助化疗的患者比较。结果显示1年总生存率为100%,胶质母细胞瘤2年总生存率为39.4%、间变性星形细胞瘤为58.3%;再干预后6个月无进展生存率分别为53.03%和75.0%。作者认为再干预对选定患者似乎是可行且安全的。

要点

  • 78例高级别胶质瘤患者中55例接受再手术,15例需第三次手术,8例需第四次手术。
  • 胶质母细胞瘤2年总生存率39.4%,间变性星形细胞瘤58.3%。
  • 再干预后6个月无进展生存率:胶质母细胞瘤53.03%,间变性星形细胞瘤75.0%。

核心结论

  • 数据表明多次手术后在总生存、无进展生存和临床状况方面结果良好,再干预对选定患者似乎是可行且安全的解决方案。

研究设计与样本

  • 观察性分析队列研究,纳入2004至2014年接受手术的78例高级别胶质瘤患者,并与78例接受辅助化疗的高级别胶质瘤患者进行比较。
  • 纳入标准为美国麻醉医师协会评分1-3分、卡氏功能状态评分>60分、首次手术后≥4个月再干预。

主要发现

  • 1年总生存率为100%。
  • 2年总生存率:胶质母细胞瘤为39.4%,间变性星形细胞瘤为58.3%。
  • 再干预后6个月无进展生存率:胶质母细胞瘤为53.03%,间变性星形细胞瘤为75.0%。
  • 78例患者中55例接受再手术,15例需第三次干预,8例需4次手术;仅2例发生主要并发症。
  • 统计分析显示并发症或神经功能恶化无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The benefits of multiple interventions on the recurrence of high-grade gliomas are renowned. However, the real effect of repeated operations on the survival parameters does not seem to have been assessed. The aim of the present study was to determine whether reoperation for selected patients is safe and feasible. METHODS: A total of 78 patients with high-grade glioma had undergone surgery from 2004 to 2014. All the patients had met the following inclusion criteria: American Society of Anesthesiologists score 1-3, Karnofsky performance scale score >60, and reintervention ≥4 months after the first surgery. The following parameters were evaluated: overall survival (OS) after diagnosis and reintervention, progression-free survival (PFS) after reintervention, number of surgical procedures, and OS of patients who had undergone surgery >2 times. The results were compared with those of 78 patients with high-grade glioma who had undergone adjuvant chemotherapy. RESULTS: OS at 1 year was 100%. At 2 years, OS was 39.4% for those with glioblastoma and 58.3% for those with anaplastic astrocytoma. PFS after 6 months was 53.03% for glioblastoma and 75.0% for anaplastic astrocytoma. Of the 78 patients, 55 had undergone reoperation, with 15 requiring a third intervention and 8 requiring 4. Major complications developed in only 2 patients. Statistical analysis revealed no significant differences in complications or worsening neurological status. CONCLUSIONS: These data showed excellent outcomes in terms of OS and PFS and clinical conditions after multiple surgical procedures. Therefore, reintervention appears to be a feasible and safe solution for selected patients.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Salvati M, Pesce A, Palmieri M, et al. The Role and Real Effect of an Iterative Surgical Approach for the Management of Recurrent High-Grade Glioma: An Observational Analytic Cohort Study. World Neurosurg. 2019. PMID: 30610982. doi:10.1016/j.wneu.2018.12.118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。